These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20515495)

  • 81. Caspase-3 and Bcl-2 expression in glioblastoma: an immunohistochemical study.
    Tirapelli LF; Bolini PH; Tirapelli DP; Peria FM; Becker AN; Saggioro FP; Carlotti CG
    Arq Neuropsiquiatr; 2010 Aug; 68(4):603-7. PubMed ID: 20730317
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glioblastoma: pathology, molecular mechanisms and markers.
    Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
    Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epigenetic modulation of metabolism in glioblastoma.
    Dong Z; Cui H
    Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Glioblastoma and other malignant gliomas: a clinical review.
    Omuro A; DeAngelis LM
    JAMA; 2013 Nov; 310(17):1842-50. PubMed ID: 24193082
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment.
    Delgado-Martín B; Medina MÁ
    Adv Sci (Weinh); 2020 May; 7(9):1902971. PubMed ID: 32382477
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment.
    Stoyanov GS; Dzhenkov D; Ghenev P; Iliev B; Enchev Y; Tonchev AB
    Med Oncol; 2018 Jan; 35(3):27. PubMed ID: 29387965
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epidemiologic and molecular prognostic review of glioblastoma.
    Thakkar JP; Dolecek TA; Horbinski C; Ostrom QT; Lightner DD; Barnholtz-Sloan JS; Villano JL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1985-96. PubMed ID: 25053711
    [TBL] [Abstract][Full Text] [Related]  

  • 88. CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis.
    Xuan R; Hu T; Cai L; Zhao B; Han E; Xia Z
    Cell Death Dis; 2024 Nov; 15(11):804. PubMed ID: 39516471
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response.
    Khan M; Huang X; Ye X; Zhang D; Wang B; Xu A; Li R; Ren A; Chen C; Song J; Zheng R; Yuan Y; Lin J
    Ann Med; 2024 Dec; 56(1):2405079. PubMed ID: 39387496
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review.
    Papacocea SI; Vrinceanu D; Dumitru M; Manole F; Serboiu C; Papacocea MT
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273661
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Genomic, epigenomic and transcriptomic landscape of glioblastoma.
    Dakal TC; Kakde GS; Maurya PK
    Metab Brain Dis; 2024 Dec; 39(8):1591-1611. PubMed ID: 39180605
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Bufotalin enhances apoptosis and TMZ chemosensitivity of glioblastoma cells by promoting mitochondrial dysfunction via AKT signaling pathway.
    Zhu Z; Liang S; Hong Y; Qi Y; Sun Q; Zhu X; Wei Y; Xu Y; Chen Q
    Aging (Albany NY); 2024 May; 16(10):9264-9279. PubMed ID: 38809514
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Investigating the Association between the Autophagy Markers LC3B,
    Danish F; Qureshi MA; Mirza T; Amin W; Sufiyan S; Naeem S; Arshad F; Mughal N
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203743
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review.
    Nafe R; Hattingen E
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626776
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment.
    Wan S; Zhang G; Liu R; Abbas MN; Cui H
    Cell Commun Signal; 2023 May; 21(1):115. PubMed ID: 37208730
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Formation of Morphologically Stable Lipid Nanocarriers for Glioma Therapy.
    Pavlov R; Romanova E; Kuznetsov D; Lyubina A; Amerhanova S; Voloshina A; Buzyurova D; Babaev V; Zueva I; Petrov K; Lukashenko S; Gaynanova G; Zakharova L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835043
    [TBL] [Abstract][Full Text] [Related]  

  • 97. PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1.
    Li X; Chen G; Liu B; Tao Z; Wu Y; Zhang K; Feng Z; Huang Y; Wang H
    Cell Death Discov; 2023 Feb; 9(1):68. PubMed ID: 36805592
    [TBL] [Abstract][Full Text] [Related]  

  • 98. CHRDL1 Regulates Stemness in Glioma Stem-like Cells.
    Berglar I; Hehlgans S; Wehle A; Roth C; Herold-Mende C; Rödel F; Kögel D; Linder B
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497175
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Atypical induction of HIF-1α expression by pericellular Notch1 signaling suffices for the malignancy of glioblastoma multiforme cells.
    Lee J; Kim E; Chong K; Ryu SW; Kim C; Choi K; Kim JH; Choi C
    Cell Mol Life Sci; 2022 Oct; 79(10):537. PubMed ID: 36183290
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Emerging roles of ferroptosis in glioma.
    Shi J; Yang N; Han M; Qiu C
    Front Oncol; 2022; 12():993316. PubMed ID: 36072803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.